KENT PHARMACEUTICALS LIMITED

Active Ashford

Manufacture of basic pharmaceutical products

0 employees website.com
Manufacture of basic pharmaceutical products
K

KENT PHARMACEUTICALS LIMITED

Manufacture of basic pharmaceutical products

Founded 15 May 1997 Active Ashford, England 0 employees website.com
Manufacture of basic pharmaceutical products

Previous Company Names

PREMIER PHARMACEUTICALS LIMITED 16 Sept 1997 — 16 Sept 2008
VAUGHAN DATA LIMITED 15 May 1997 — 16 Sept 1997
Accounts Submitted 26 Jan 2026 Next due 31 Dec 2026 6 months remaining
Confirmation Submitted 15 May 2026 Next due 29 May 2027 11 months remaining
Net assets £-2M £183K 2024 year on year
Total assets £18K £43K 2024 year on year
Total Liabilities £2M £140K 2024 year on year
Charges 4
2 outstanding 2 satisfied

Contact & Details

Contact

Registered Address

2nd Floor, Connect 38 1 Dover Place Ashford Kent TN23 1FB England

Full company profile for KENT PHARMACEUTICALS LIMITED (03371228), an active company based in Ashford, England. Incorporated 15 May 1997. Manufacture of basic pharmaceutical products. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2025
Type audit-exemption-subsidiary
Next accounts 31 Mar 2026
Due by 31 Dec 2026 6 months remaining

Balance Sheet & P&L (2013–2024)

Cash in Bank

£1.00k

Decreased by £31.00k (-97%)

Net Assets

-£2.17M

Decreased by £183.00k (-9%)

Total Liabilities

£2.19M

Increased by £140.00k (+7%)

Turnover

N/A

Employees

N/A

Debt Ratio

12172%

Increased by 8810 (+262%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Mar Year End
2024
31 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Kent Pharma Holdings Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 1 Jun 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors,significant Influence Or Control As Firm

Group Structure

Group Structure

KENT PHARMACEUTICALS LIMITED Current Company

Charges

Charges

2 outstanding 2 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
15 May 2026Confirmation StatementConfirmation statement made on 15 May 2026 with no updates
26 Jan 2026AccountsAnnual accounts made up to 31 Mar 2025
26 Jan 2026OtherAudit exemption statement of guarantee by parent company for period ending 31/03/25
26 Jan 2026AccountsAnnual accounts filed
9 Jan 2026OtherNotice of agreement to exemption from audit of accounts for period ending 31/03/25
15 May 2026 Confirmation Statement

Confirmation statement made on 15 May 2026 with no updates

26 Jan 2026 Accounts

Annual accounts made up to 31 Mar 2025

26 Jan 2026 Other

Audit exemption statement of guarantee by parent company for period ending 31/03/25

26 Jan 2026 Accounts

Annual accounts filed

9 Jan 2026 Other

Notice of agreement to exemption from audit of accounts for period ending 31/03/25

Recent Activity

Latest Activity

Confirmation statement made on 15 May 2026 with no updates

3 weeks ago on 15 May 2026

Annual accounts made up to 31 Mar 2025

4 months ago on 26 Jan 2026

Audit exemption statement of guarantee by parent company for period ending 31/03/25

4 months ago on 26 Jan 2026

Annual accounts filed

4 months ago on 26 Jan 2026

Notice of agreement to exemption from audit of accounts for period ending 31/03/25

5 months ago on 9 Jan 2026